Skip to main content
. 2022 Sep 21;2022:1653290. doi: 10.1155/2022/1653290

Table 2.

Comparison of symptom scores under different gastric dilatation volumes between the two groups.

Observed indexes Control group (n = 36) Study group (n = 37)
Before treatment After treatment Before treatment After treatment
Epigastric pain
 200 ml 0.94 ± 0.23 0.72 ± 0.45 0.95 ± 0.23 0.05 ± 0.23,#
 300 ml 1.86 ± 0.76 1.06 ± 0.47 1.62 ± 0.72 0.62 ± 0.49,#
 400 ml 2.42 ± 0.65 1.47 ± 0.65 2.27 ± 0.80 1.00 ± 0.08,#
Fullness
 200 ml 1.08 ± 0.28 0.97 ± 0.17 1.14 ± 0.35 0.30 ± 0.46,#
 300 ml 1.97 ± 0.70 1.33 ± 0.79 1.65 ± 0.86 0.862 ± 0.48,#
 400 ml 2.39 ± 0.69 1.89 ± 0.68 2.49 ± 0.61 1.32 ± 0.67,#
Nausea or vomiting
 200 ml 1.00 ± 0.24 0.67 ± 0.48 0.97 ± 0.29 0.11 ± 0.31,#
 300 ml 1.78 ± 0.68 1.14 ± 0.59 1.92 ± 0.80 0.65 ± 0.54,#
 400 ml 2.19 ± 0.82 1.44 ± 0.69 1.95 ± 0.81 0.97 ± 0.50,#

Note: meant P < 0.05 vs. before treatment; # meant P < 0.05 vs. after treatment in control group.